Evidence map›Paper›PMID 16501114›Full record

ArticleJournal of virology2006

A hydrophobic binding surface on the human immunodeficiency virus type 1 Nef core is critical for association with p21-activated kinase 2.

Kristin Agopian, Bangdong L Wei, J Victor Garcia, Dana Gabuzda

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Improving HIV proteome annotation: new features of BioAfrica HIV Proteomics Resource.Database : the journal of biological databases and curation · 2016
    Article
  4. Article
  5. Article
  6. Article
  7. The activity of Nef on HIV-1 infectivity.Frontiers in microbiology · 2014
    Review
  8. Article
  9. Article
  10. Article
  11. HIV-1 Nef interferes with T-lymphocyte circulation through confined environments in vivo.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Mechanisms of HIV-1 Nef function and intracellular signaling.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2011
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Kristin AgopianDepartment of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, JFB 816, 44 Binney St., Boston, Massachusetts 02115, USA.
Bangdong L Wei
J Victor Garcia
Dana Gabuzda
The University of Texas Southwestern Medical Center · USDana-Farber Cancer Institute · USHarvard University · US

Funding

NEF FUNCTIONR01AI033331 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI GARCIA-MARTINEZ, J. VICTOR · 1994 to 2010
$4.4M
ROLE OF APOPTOSIS IN HIV-1 DEMENTIAR01NS035734 · NINDS · DANA-FARBER CANCER INSTITUTE · PI GABUZDA, DANA H. · 1996 to 2003
$1.4M
NIAID NIH HHS AI33331NIAID NIH HHS R01 AI033331NINDS NIH HHS NS35734NINDS NIH HHS R01 NS035734
6 · The paper itself

Abstract

The interaction of human immunodeficiency virus type 1 (HIV-1) Nef with p21-activated kinase 2 (Pak2) has been proposed to play an important role in T-cell activation and disease progression during viral infection. However, the mechanism by which Nef activates Pak2 is poorly understood. Mutations in most Nef motifs previously reported to be required for Pak2 activation (G2, PxxP72, and RR105) also affect other Nef functions, such as CD4 or major histocompatibility complex class I (MHC-I) downregulation. To better understand Nef interactions with Pak2, we performed mutational analysis of three primary HIV-1 Nef clones that exhibited similar capacities for downregulation of CD4 and MHC-I but variable abilities to associate with activated Pak2. Our results demonstrate that Nef amino acids at positions 85, 89, 187, 188, and 191 (L, H, S, R, and F in the clade B consensus, respectively) are critical for Pak2 association. Mutation of these Nef residues dramatically altered association with Pak2 without affecting Nef expression levels or CD4 and MHC-I downregulation. Furthermore, compensation occurred at positions 89 and 191 when both amino acids were substituted. Since residues 85, 89, 187, 188, and 191 cluster on the surface of the Nef core domain in a region distinct from the dimerization and SH3-binding domains, we propose that these Nef residues form part of a unique binding surface specifically involved in association with Pak2. This binding surface includes exposed and recessed hydrophobic residues and may participate in an as-yet-unidentified protein-protein interaction to facilitate Pak2 activation.

Indexed as

Hydrophobic and Hydrophilic InteractionsAmino Acid SequenceAnimalsBinding SitesCell LineGene Products, nefGenes, nefHIV-1HIV InfectionsHumansModels, MolecularMolecular Sequence DataMutationnef Gene Products, Human Immunodeficiency Virusp21-Activated KinasesPhylogenyGene Products, nefnef Gene Products, Human Immunodeficiency Virusp21-Activated KinasesPAK2 protein, humanProtein Serine-Threonine Kinases

Identifiers

PMID16501114
PMCPMC1395437
OpenAlexW2147582981

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.